Furthermore, proteomic characteristics, determined by gene ontology analysis, of plasma microparticles from patients with T2D showed that levels of S100A8/A9 were upregulated26 (Table 1). This evidence concerns the gene IGKV1D-22 and type 2 diabetes mellitus.